Thursday, July 15 ⁽⁴⁾

PUMP Intrathecal Therapy: Case-Based Learning Featured

Intrathecal drug delivery is a well-established intervention for chronic pain and severe spasticity with over 3 decades of clinical use. Safe and effective utilization of this technique requires solid cognitive and technical skills. The purpose of this course will be to instruct clinicians on these techniques through case-based scenarios. Strategies to improve patient selection, trialing, implantation, post-implantation management, troubleshooting, and therapy optimization will be discussed. Multiple medical specialists would find this course of interest including neurology, neurosurgery, anesthesiology, and physical medicine and rehabilitation. This course will also be of interest to many allied health professionals such as physical therapy, occupational therapy, nursing, pharmacy, case management, and bioengineering.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Congress of Neurological Surgeons (CNS) and the North American Neuromodulation Society. The CNS is accredited by ACCME to provide continuing medical education for physicians. The CNS designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APP Advanced Practice Provider Course Featured

The course will provide advanced practice providers an overview of topics in neuromodulation through lectures, case studies, and panel discussions. The material will be presented by physicians and APP faculty and will be relevant for anyone interested in or involved in the management of patients in pain management, neurosurgery, neurology, orthopedic or physical medicine, and rehabilitation practice.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Congress of Neurological Surgeons (CNS) and the North American Neuromodulation Society. The CNS is accredited by ACCME to provide continuing medical education for physicians. The CNS designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAIN Neuromodulation for Advanced Implantable Therapies: A Hands-On Cadaver Course for Pain Fellows

This event combines didactics on spinal cord stimulation and intrathecal drug delivery systems, as well as other approved clinical applications of neuromodulation strategies, with practical hands-on training in a cadaver laboratory. This premier training opportunity offers pain medicine fellows the opportunity to learn cutting-edge neuromodulation techniques and principles of implementation in clinical practice. Techniques explored include spinal cord trials and implants, intrathecal drug delivery trials and implants, peripheral nerve stimulation, suturing, and maintenance of neuromodulation therapies. Participants are under the direction of experienced faculty. This workshop's intent is to foster a platform for networking and to create excitement in the neuromodulation space.

This activity is not eligible for CME credits.

III NANS I3: Innovation in a Hyper-Connected World

This year's NANS Invention, Investment, and Invigoration (I³) Forum is designed to provide an interactive platform for review and discussion of emerging information technology topics in healthcare, peripheral nerve stimulation technologies, and a discussion on accelerating innovation. The forum includes clinicians, scientists, engineers, industry, and investors, among others. The course will include the following sessions:

• Neuromodulation Integration With Information Technology
• Innovation – How to Accelerate?
• Evolving Peripheral Nerve Stimulation Neuromodulation Therapies

Join us at the world's premier forum for invention, investment, and invigoration in neuromodulation: NANS I³.

This activity is not eligible for CME credits.